Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Event-free survival after 68 Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy.
Ceci F, Rovera G, Iorio GC, Guarneri A, Chiofalo V, Passera R, Oderda M, Dall'Armellina S, Liberini V, Grimaldi S, Bellò M, Gontero P, Ricardi U, Deandreis D. Ceci F, et al. Among authors: rovera g. Eur J Nucl Med Mol Imaging. 2022 Jul;49(9):3257-3268. doi: 10.1007/s00259-022-05741-9. Epub 2022 Feb 26. Eur J Nucl Med Mol Imaging. 2022. PMID: 35217883 Free PMC article.
The role of PET/CT in thyroid autoimmune diseases.
Califaretti E, Dall'armellina S, Rovera G, Finessi M, Deandreis D. Califaretti E, et al. Among authors: rovera g. Q J Nucl Med Mol Imaging. 2022 Sep;66(3):218-228. doi: 10.23736/S1824-4785.22.03464-1. Epub 2022 May 25. Q J Nucl Med Mol Imaging. 2022. PMID: 35612371
Robot-assisted PSMA-radioguided Surgery to Assess Surgical Margins and Nodal Metastases in Prostate Cancer Patients: Report on Three Cases Using an Intraoperative PET-CT Specimen Imager.
Oderda M, Grimaldi S, Rovera G, Delsedime L, D'Agate D, Lavagno F, Marquis A, Marra G, Molinaro L, Deandreis D, Gontero P. Oderda M, et al. Among authors: rovera g. Urology. 2023 Dec;182:e257-e261. doi: 10.1016/j.urology.2023.08.013. Epub 2023 Sep 3. Urology. 2023. PMID: 37669707
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study).
Bauckneht M, Lanfranchi F, Albano D, Triggiani L, Linguanti F, Urso L, Mazzola R, Rizzo A, D'Angelo E, Dondi F, Mataj E, Pedersoli G, Abenavoli EM, Vaggelli L, Detti B, Ortolan N, Malorgio A, Guarneri A, Garrou F, Fiorini M, Grimaldi S, Ghedini P, Iorio GC, Iudicello A, Rovera G, Fornarini G, Bongiovanni D, Marcenaro M, Pazienza FM, Timon G, Salgarello M, Racca M, Bartolomei M, Panareo S, Ricardi U, Bertagna F, Alongi F, Barra S, Morbelli S, Sambuceti G, Belgioia L. Bauckneht M, et al. Among authors: rovera g. J Nucl Med. 2024 Aug 1;65(8):1202-1209. doi: 10.2967/jnumed.124.267586. J Nucl Med. 2024. PMID: 38906557 Free PMC article.
Comparative Performance of 68Ga-PSMA-11 PET/CT and Conventional Imaging in the Primary Staging of High-Risk Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy.
Rovera G, Grimaldi S, Oderda M, Marra G, Calleris G, Iorio GC, Falco M, Grossi C, Passera R, Campidonico G, Mangia ML, Deandreis D, Faletti R, Ricardi U, Gontero P, Morbelli S. Rovera G, et al. Diagnostics (Basel). 2024 Sep 5;14(17):1964. doi: 10.3390/diagnostics14171964. Diagnostics (Basel). 2024. PMID: 39272748 Free PMC article.
253 results